ORIGINAL RESEARCH article
Front. Endocrinol.
Sec. Obesity
Volume 16 - 2025 | doi: 10.3389/fendo.2025.1589444
Centella asiatica extract improves senescence-associated metabolic dysfunction by targeting inflammation in adipose tissue and macrophage in obesity-induced insulin resistance mice
Provisionally accepted- 1Department of Pharmacology and Therapeutics, Faculty of Medicine, University of Indonesia, Jakarta, Indonesia
- 2Metabolic, Cardiovascular, and Aging Cluster, Indonesia Medical Education and Research Institute (IMERI), Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia, Jakarta, Jakarta, Indonesia
- 3Master Program in Biomedical Sciences, Faculty of Medicine, University of Indonesia, Jakarta, Jakarta, Indonesia
- 4Department of Cardiovascular Aging, National Cerebral and Cardiovascular Center Research Institute, Osaka, Japan
- 5Indonesian Medical Education and Research Institute, University of Indonesia, Jakarta Pusat, Jakarta, Indonesia
- 6Department of Medical Pharmacy, Faculty of Medicine, University of Indonesia, Jakarta, Jakarta, Indonesia
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Insulin Resistance (IR) is a complication that frequently occurs in obesity. The inflammation-mediated senescence in White Adipose Tissue (WAT) is important in obesity-induced IR. Centella asiatica (CA) is a potential medicinal plant with anti-aging and anti-obesity properties. Here, we explored the effect of CA on obesity-mediated IR in mice fed with a High Fat-High Fructose (HFHF) diet and treated simultaneously with CA at 150 mg/kgBW (CA150) or 300 mg/kgBW (CA300). The total body mass and visceral WAT weight in both CA groups decreased in comparison with HFHF group alone. We demonstrated that HFHF-diet mice treated with CA300 improved insulin sensitivity and enhanced Irs-1 activation in WAT. CA300, but not CA150, prevented the senescence phenotype in WAT, represented by decreased Senescence-associated beta-galactosidase (SA-β-Gal) activity and diminished Cdkn2a and Cdkn1a expression levels at mRNA level. Mechanistically, CA300 prevented the enhancement of Il6 and Il1b mRNA expression levels and macrophage activity in the immunostaining analysis of WAT. In vitro, RAW264.7 cells stimulated with high glucose and low dose of Lipopolysaccharides (LPS) also confirmed that CA 200 μg/ml alleviated the expression levels of M1 markers such as Ccl2, Il6, Il1b, and Tnf at mRNA level. Our data indicated that CA has therapeutic potential for obesity-mediated IR by suppressing proinflammatory M1 macrophages and preventing inflammation-induced senescence in WAT.
Keywords: Centella asiatica, Inflammation, M1 pro-inflammatory macrophage, senescence, white adipose tissue, Obesity, Insulin Resistance
Received: 14 Mar 2025; Accepted: 02 Jul 2025.
Copyright: © 2025 Barinda, Arozal, Dwita, Safutra, Shimizu, Hsiao, Sandora, Hakim, Khatimah and Hardi. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Wawaimuli Arozal, Department of Pharmacology and Therapeutics, Faculty of Medicine, University of Indonesia, Jakarta, Indonesia
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.